- Home
- FBIO vs BDL Comparison
FBIO vs BDL Comparison
Compare FBIO & BDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBIO
- BDL
- Stock Information
- Founded
- FBIO 2006
- BDL 1959
- Country
- FBIO United States
- BDL United States
- Employees
- FBIO N/A
- BDL N/A
- Industry
- FBIO Biotechnology: Pharmaceutical Preparations
- BDL Restaurants
- Sector
- FBIO Health Care
- BDL Consumer Discretionary
- Exchange
- FBIO Nasdaq
- BDL Nasdaq
- Market Cap
- FBIO 49.1M
- BDL 44.1M
- IPO Year
- FBIO N/A
- BDL N/A
- Fundamental
- Price
- FBIO $1.89
- BDL $27.36
- Analyst Decision
- FBIO Strong Buy
- BDL
- Analyst Count
- FBIO 3
- BDL 0
- Target Price
- FBIO $21.00
- BDL N/A
- AVG Volume (30 Days)
- FBIO 178.7K
- BDL 3.7K
- Earning Date
- FBIO 05-15-2025
- BDL 05-19-2025
- Dividend Yield
- FBIO N/A
- BDL 3.84%
- EPS Growth
- FBIO N/A
- BDL 14.76
- EPS
- FBIO N/A
- BDL 2.18
- Revenue
- FBIO $57,784,000.00
- BDL $198,785,000.00
- Revenue This Year
- FBIO $63.20
- BDL N/A
- Revenue Next Year
- FBIO $66.70
- BDL N/A
- P/E Ratio
- FBIO N/A
- BDL $12.56
- Revenue Growth
- FBIO N/A
- BDL 9.31
- 52 Week Low
- FBIO $1.33
- BDL $22.61
- 52 Week High
- FBIO $2.89
- BDL $29.25
- Technical
- Relative Strength Index (RSI)
- FBIO 60.90
- BDL 63.58
- Support Level
- FBIO $1.66
- BDL $26.40
- Resistance Level
- FBIO $1.96
- BDL $28.50
- Average True Range (ATR)
- FBIO 0.11
- BDL 0.84
- MACD
- FBIO 0.02
- BDL 0.42
- Stochastic Oscillator
- FBIO 80.56
- BDL 80.67
About FBIO Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.
About BDL Flanigan's Enterprises Inc.
Flanigan'S Enterprises Inc operates as a chain of small cocktail lounges and packages liquor stores throughout South Florida. The business activity is principally conducted in two segments namely Restaurant and Package liquor store segment. Its Restaurant segment offers alcoholic beverages and full food service, and Package stores consist of retail liquor sales and related items. Its menu consists of a wide variety of options including prime rib, steaks, pasta, entree salads, burgers, a variety of sandwiches, and oversized signature desserts. The company generates maximum revenue from Restaurant segment.